Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Antibodies binding to CD34+/CD36+ fetal but not to adult cells

A fetal cell, cell antigen technology, applied in the field of antibodies that bind to fetal but not adult CD34+/CD36+ cells

Inactive Publication Date: 2007-07-18
THE BOARD OF TRUSTEES OF THE UNIV OF ILLINOIS
View PDF4 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

A particular limitation is that the relevant maternal and fetal cells used for this purpose are primarily stem cells and cells in the BFU and CFU stages of differentiation

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Antibodies binding to CD34+/CD36+ fetal but not to adult cells
  • Antibodies binding to CD34+/CD36+ fetal but not to adult cells

Examples

Experimental program
Comparison scheme
Effect test

example 1

[0044] Example 1: Preparation of fetal liver cells

[0045] Fetal liver cells can be obtained from Cambrex Bio Science, Walkersville, M.D. Alternatively, it can be isolated from fetal livers (FL, 15-22 weeks of gestation) from 5 different donors, as described below.

[0046] Fetal livers from five donors were homogenized in DPBS / 0.2% BSA solution and passed through a metal sieve. Among them, DPBS does not contain Ca ++ / Mg ++ Dulbecco's phosphate buffered saline solution (Biowhittaker, Walkersville, MD); BSA is bovine serum albumin (Sigma St. Louis, MO), and contains 50 μg / ml gentamicin sulfate (Life Technologies, Grand Island NY). CD34 + Cells can be sorted from the homogenate using MACS or FACS as described in Example 3. Or, in accordance with the MACS or FACS method described in Example 3 to sort CD34 + Before the cells, the homogenate was further purified as described below.

[0047] Use immunomagnetic microspheres to exclude mature red blood cells and other lineage-positive c...

example 2

[0048] Example 2: Preparation of mobilized peripheral blood cells

[0049] The mobilized peripheral blood cells are obtained from Cambrex, and can also be obtained from the following methods.

example 3

[0052] Example 3: Adult and fetal CD34 + Purification of progenitor cells

[0053] The fetal liver cells and MPB mononuclear cell fractions of Example 1 and Example 2 were recorded in CD34 according to any of the following methods. + Cell enrichment.

[0054] MACS method

[0055] Fetal liver cells and MPB monocytes were prepared according to the methods of Examples 1 and 2, respectively, and MACS CD34 was used + The separation kit (Miltenyi Biotec, Auburn, CA) is in accordance with the instructions for use in CD34 + Cellular immune magnetic beads are enriched. Briefly, monocytes are incubated with hapen-labeled anti-CD34 antibody (QBEND-10, BD Pharmingen, San Diego, CA) in 0.1% human IgG (Bayer Elkhart, IN) as a blocking agent, and then ligated with Co-culture to MACS microbeads against hapen. The labeled cells are filtered through a 30μm nylon mesh to remove cell clumps and aggregates. Then labeled CD34 + The cells are captured from the mixture through a high gradient magnetic se...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

This invention relates to antibodies that specific bind to fetal CD36+ cells in preference to binding to maternal CD36+ cells and methods for using these antibodies to detect and separate fetal cells from adult biological fluids including maternal peripheral blood.

Description

[0001] This application claims the priority of U.S. Patent Application No. 60 / 579,693 filed on June 14, 2004 and U.S. Patent Application No. 60 / 618,963 filed on October 15, 2004. The contents of the above-mentioned patent applications are expressly referenced The method is incorporated into this article. Technical field [0002] The present invention relates to fetal CD36 + Cells instead of maternal CD36 + Cell-bound antibodies, and the use of these antibodies to detect and isolate fetal cells from maternal peripheral blood. Background technique [0003] The discovery of fetal red blood cells in maternal blood after childbirth was reported by Zipursky in 1959 ("Foetal erythrocytes in the maternal circulation," Lancet 1:45 1-52). Later, it was discovered that fetal red blood cells, lymphocytes and trophoblast cells were present in the maternal blood during pregnancy (Herzenberg et al., 1979, Proc Natl Acad Sci USA, 76: 1453-1455; Bianchi et al., 1990, Natl Acad Sci USA, 87: 3279-83...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C07K16/28C12Q1/68G01N33/12
Inventor 阿伦·夏尔马舍曼·伊莱亚斯
Owner THE BOARD OF TRUSTEES OF THE UNIV OF ILLINOIS
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products